Guardant Health Companion Diagnostic Becomes The First Blood Test To Gain Approval In Singapore For Advanced Solid Cancers
Medical Devices / Singapore / Wed 31 May, 2023
Key View
- The regulatory approval of Guardant360 CDx in Singapore will be crucial in improving cancer diagnosis and effective treatment for the disease in the country.
- We expect to see more approvals of Guardant360 CDx in key markets such as the US, Asia-Pacific and Europe, supported by Guardant Health’s partnerships with targeted oncology